Advanced Kaposi Sarcoma

1 clinical trials · Condition

Record	Firm	Date
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV (NCT04514484)	National Cancer Institute (NCI)	2021-11-22

Every clearance here is in the API, with alerts when new ones post.